Oral phosphodiesterase type 5 inhibitors and priapism: A VigiBase analysis. Pharmacoepidemiology and drug safety 2023 https://researcherprofiles.org/profile/447962317 37909414 Abbasi B, Shaw NM, Lui JL, Hakam N, Nabavizadeh B, Breyer BN
